Jump to content
Sign in to follow this  
mmafighting

Daniel Pineda set to appeal ‘irregular’ test result with Nevada Commission, PFL designates alternate for finals

Recommended Posts

Daniel Pineda is scheduled to fight on the Bellator 161 undercard Friday night in Cedar Park, Texas.Daniel Pineda is scheduled to fight on the Bellator 161 undercard Friday night in Cedar Park, Texas. | Bellator

Daniel Pineda may or may not be competing in the featherweight finals for the PFL on Dec. 31.

Weeks after it was first reported that Pineda had a drug test flagged by the Nevada State Athletic Commission, the PFL has announced that they have designated alternates eligible to serve as replacements in case any of the finalists are unable to compete.

According to the PFL, Pineda will go before the Nevada State Athletic Commission on Dec. 18 to appeal an “irregular test result” from his playoff fights in October.

“The PFL believes all athletes deserve due process and will, within reason, provide the fighters who earned their way into the finals every opportunity to compete on New Year’s Eve,” PFL CEO Peter Murray said in a statement on Wednesday. “The League, as always, will abide by the final ruling of the commission.”

If Pineda faces a sanction for the irregular drug test result, Alex Gilpin would then return for the finals to face Palmer for the third time this season. Palmer has defeated Gilpin by unanimous decision in their two previous meetings.

Welterweight alternate Glaico Franco also has a hearing with the Nevada Commission on the same day for a separate failed drug test. If he’s unable to serve as the alternate, Chris Curtis would then be on standby for the welterweight finals between David Michaud and Ray Cooper.

Here is the full list of alternates for the PFL Finals on Dec. 31 from New York:

Featherweight — Alex Gilpin

Women’s LightweightSarah Kaufman

Lightweight — Chris Wade

Welterweight — Glaico Franca (Second alternate is Chris Curtis)

Light HeavyweightBozigit Ataev

HeavyweightDenis Goltsov

Afficher l’article complet

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
Sign in to follow this  

© IKUSA 2003 - 2018 tous droits réservés

×